AU2001288053A1 - N-substituted benzothiophenesulfonamide derivatives - Google Patents

N-substituted benzothiophenesulfonamide derivatives

Info

Publication number
AU2001288053A1
AU2001288053A1 AU2001288053A AU8805301A AU2001288053A1 AU 2001288053 A1 AU2001288053 A1 AU 2001288053A1 AU 2001288053 A AU2001288053 A AU 2001288053A AU 8805301 A AU8805301 A AU 8805301A AU 2001288053 A1 AU2001288053 A1 AU 2001288053A1
Authority
AU
Australia
Prior art keywords
agent
substituted benzothiophenesulfonamide
substituted
chymase
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288053A
Other languages
English (en)
Inventor
Takeshi Hasegawa
Shin-Ichi Kazayama
Hidekazu Masaki
Takahiro Morita
Shoji Satoh
Atsuo Takahashi
Akira Tatsui
Hideki Yamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toa Eiyo Ltd
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Publication of AU2001288053A1 publication Critical patent/AU2001288053A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2001288053A 2000-09-18 2001-09-17 N-substituted benzothiophenesulfonamide derivatives Abandoned AU2001288053A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000282046 2000-09-18
JP2000-282046 2000-09-18
JP2001122972 2001-04-20
JP2001-122972 2001-04-20
PCT/JP2001/008061 WO2002022595A1 (fr) 2000-09-18 2001-09-17 Derives de benzothiophenesulfonamide substitue en n

Publications (1)

Publication Number Publication Date
AU2001288053A1 true AU2001288053A1 (en) 2002-03-26

Family

ID=26600125

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288053A Abandoned AU2001288053A1 (en) 2000-09-18 2001-09-17 N-substituted benzothiophenesulfonamide derivatives

Country Status (8)

Country Link
EP (1) EP1325920B1 (fr)
JP (1) JP3847711B2 (fr)
CN (1) CN1245400C (fr)
AT (1) ATE478857T1 (fr)
AU (1) AU2001288053A1 (fr)
CA (1) CA2422807C (fr)
DE (1) DE60142914D1 (fr)
WO (1) WO2002022595A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003335670A (ja) * 2002-03-15 2003-11-25 Toa Eiyo Ltd 癒着防止剤
DE60333351D1 (de) * 2002-03-15 2010-08-26 Toa Eiyo Ltd N-substituiertes benzothiophensulfonamidderivat
AU2004266536A1 (en) * 2003-08-22 2005-03-03 Teijin Pharma Limited Drug containing chymase inhibitor as the active ingredient
EP2118062A1 (fr) * 2007-01-10 2009-11-18 F. Hoffmann-Roche AG Dérivés de sulfonamide en tant qu'inhibiteurs de la chymase
US20090163586A1 (en) 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
EP2651957B1 (fr) * 2010-12-16 2015-02-18 Allergan, Inc. Dérivés phosphoreux en tant que modulateurs de récepteur de chimiokine
WO2014159657A1 (fr) 2013-03-12 2014-10-02 Allergan, Inc. Dérivés de pyridinyl- et pyrimidinyl-sulfonamide en tant que modulateurs de récepteurs de chimiokine.
WO2015084869A1 (fr) 2013-12-02 2015-06-11 Allergan, Inc. Dérivés de benzothiophène-sulfonamides utilisés comme modulateurs des récepteurs des chimiokines
CN111285844B (zh) * 2020-02-24 2022-08-12 河南师范大学 具有生物活性的苯并噻吩取代酰胺类化合物及其合成方法和应用
TW202404601A (zh) 2022-04-05 2024-02-01 加拿大商索科普拉健康與人類科學兩合公司 用於選擇性消退血栓性或血栓栓塞性疾病中血栓的凝乳酶抑制劑

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299246B6 (cs) * 1995-04-04 2008-05-28 Encysive Pharmaceuticals Inc. Sulfonamid, farmaceutická kompozice s jeho obsahem a jeho použití pro výrobu léciva
WO1997011941A1 (fr) * 1995-09-28 1997-04-03 Suntory Limited Derives de la quinazoline et leurs emplois
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
JP2000095770A (ja) * 1998-07-22 2000-04-04 Toa Eiyo Ltd Ｎ置換チアゾリジン誘導体及びそれを含有する医薬
HUP0103387A3 (en) * 1998-08-21 2002-07-29 Daiichi Asubio Pharma Co Ltd Quinazoline derivatives preparation thereof, medicament containing them and their intermediates
GB9818914D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
GB9818916D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
JP4491866B2 (ja) * 1999-09-30 2010-06-30 三菱化学株式会社 アシルスルホンアミド誘導体

Also Published As

Publication number Publication date
ATE478857T1 (de) 2010-09-15
WO2002022595A1 (fr) 2002-03-21
CA2422807A1 (fr) 2003-03-18
EP1325920A1 (fr) 2003-07-09
CA2422807C (fr) 2009-12-08
JPWO2002022595A1 (ja) 2004-01-22
CN1245400C (zh) 2006-03-15
EP1325920B1 (fr) 2010-08-25
JP3847711B2 (ja) 2006-11-22
EP1325920A4 (fr) 2005-02-02
CN1458928A (zh) 2003-11-26
DE60142914D1 (de) 2010-10-07

Similar Documents

Publication Publication Date Title
WO2006028958A3 (fr) Inhibiteurs pyridyles de la signalisation hedgehog
WO2004075865A3 (fr) Modulation selective d'une activite biologique induite par le recepteur tlr
ATE286710T1 (de) Antischuppenmittel
AU2003244463A1 (en) 2,4,6-triamino-1,3,5-triazine derivative
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
EP1944059A3 (fr) Dispositif de désynchronisation de l'activité cérébrale neuronale
PL1845095T3 (pl) Pochodne 1-tio-D-glucitolu
WO2007024971A3 (fr) Antagonistes du trajet hedgehog pour traiter des maladies
NO20044442L (no) Fosfatprodroger av fluoroksindoler
WO2000077246A3 (fr) COMPOSES INHIBANT L'ACTIVITE DU COMPLEXE FVIIa/TF
WO2006127379A3 (fr) Composes modulant par2 et leur utilisation
AU2001288053A1 (en) N-substituted benzothiophenesulfonamide derivatives
WO2004053069A3 (fr) Protection de cellules souches contre des agents cytotoxiques par modulation des voies de signalisation de la $g(b)-catenine
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
WO2002034201A3 (fr) Utilisation d'inhibiteurs de l'apoptose des pericytes pour le traitement et/ou la prevention de la retinopathie diabetique
WO2009015369A3 (fr) Composés qui inhibent l'activité de la bêta-sécrétase et procédés d'utilisation de ceux-ci
WO2005005382A3 (fr) Composes, compositions et procedes associes
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
WO2005014576A8 (fr) Derive d'isoquinoline, procede permettant de produire ce derive, et utilisation de ce derive
WO2003090674A3 (fr) Composes, compositions et procedes de traitement ou de prevention d'infections virales et de maladies associees
EP1486494A4 (fr) Derive du benzothiophenesulfonamide substitue en n
MXPA03011790A (es) Agente para la procteccion de neuronas de la retina.
DK1133314T3 (da) Protein C til behandling af seglcellesygdom og thalassæmi
TW200509798A (en) Phenylsulfonyl carbamate derivative and plant disease control agent for agricultural or horticultural use
WO2001011968A3 (fr) Composes spiro heterocycliques utilises comme pesticides